These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 21972160)

  • 1. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?
    Shah R; Thomson A; Atianzar K; Somma K; Mehra A; Clavijo L; Matthews RV; Shavelle DM
    Cardiovasc Revasc Med; 2012; 13(2):101-5. PubMed ID: 22406055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Al-Husami W; Yturralde F; Mohanty G; Pastore C; Lotun K; Venesy D; Waxman S; Pyne C; Gossman D; Nesto R; Piemonte T
    J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    Cardiol Res; 2012 Apr; 3(2):54-66. PubMed ID: 28348673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
    J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
    Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Sindaco FD; Ragni T; Allegri M; Ambrosio G
    Acute Card Care; 2006; 8(1):35-40. PubMed ID: 16720426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Vis MM; Koch KT; Paulus WJ; de Mol BA; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):187-94. PubMed ID: 19941329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in hemodynamics with a new, larger-volume (50 cc) intra-aortic balloon for high-risk percutaneous coronary intervention.
    Nair PK; Scolieri S; Lee AB
    J Invasive Cardiol; 2011 Apr; 23(4):162-6. PubMed ID: 21474851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
    ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
    O'Neill WW; Kleiman NS; Moses J; Henriques JP; Dixon S; Massaro J; Palacios I; Maini B; Mulukutla S; Dzavík V; Popma J; Douglas PS; Ohman M
    Circulation; 2012 Oct; 126(14):1717-27. PubMed ID: 22935569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.